Strategy to Reduce Atherosclerosis Development Involving Administration of Rimonabant: The Intravascular Ultrasound Study - STRADIVARIUS

Description:

The goal of this trial was to evaluate treatment with the cannabinoid type 1 receptor inhibitor rimonabant compared with placebo in obese patients with the metabolic syndrome.